Cite
HARVARD Citation
Tamborlane, W. et al. (2022). Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. Lancet. 10 (5), pp. 341-350. [Online].